PP
SRTA

Paloma Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Paloma Partners’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-262,500
Closed -$2.64M – 1670
2020
Q3 		$2.64M Hold
262,500
– – 0.07% 304
2020
Q2 		$2.62M Hold
262,500
– – 0.05% 516
2020
Q1 		$2.54M Buy
+262,500
New +$2.61M 0.14% 104

Other funds holding SRTA

HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Paloma Partners's SRTA Position: Q4 2020 in Review

Paloma Partners sold out of Strata Critical Medical Inc (SRTA) in Q4 2020, closing a stake of 262,500 shares — an estimated $2.64M sold.

Paloma Partners first reported a position in SRTA in Q1 2020 and held it in 3 quarters. The position peaked at $2.64M in Q3 2020. 84 funds tracked by Wall St. Rank hold SRTA as of Q4 2020.

  • Paloma Partners reported no remaining Strata Critical Medical Inc position as of Q4 2020 after selling out during the quarter.
  • Paloma Partners sold 262,500 Strata Critical Medical Inc shares in Q4 2020, an estimated $2.64M.
  • Paloma Partners first reported a position in Strata Critical Medical Inc in Q1 2020 and held it in 3 quarters.
  • Paloma Partners's Strata Critical Medical Inc position peaked at $2.64M in Q3 2020.
  • 84 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.